XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Dec. 23, 2021
Sep. 13, 2021
Sep. 09, 2021
Aug. 21, 2020
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Oct. 31, 2017
Product Information [Line Items]                
Common Stock, Par or Stated Value Per Share         $ 0.02   $ 0.02  
Shares Issued, Price Per Share               $ 0.15
Inventory adjustments         $ 22,000   $ 388,000  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]                
Product Information [Line Items]                
Concentration risk percentage         10.00% 31.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]                
Product Information [Line Items]                
Concentration risk percentage         3.00% 8.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]                
Product Information [Line Items]                
Concentration risk percentage         29.00% 57.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]                
Product Information [Line Items]                
Concentration risk percentage         6.00% 8.00%    
Warrant [Member]                
Product Information [Line Items]                
Anti-dilutive securities excluded from computation of EPS         3,556 29,314    
Share-Based Payment Arrangement, Option [Member]                
Product Information [Line Items]                
Anti-dilutive securities excluded from computation of EPS         11,930 13,596    
Convertible Preferred Stock [Member]                
Product Information [Line Items]                
Anti-dilutive securities excluded from computation of EPS           43,000    
Stock conversion, shares issued           6,570,000    
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member]                
Product Information [Line Items]                
Stock Issued During Period, Shares, Acquisitions       483,334        
Common Stock, Par or Stated Value Per Share       $ 0.02        
Shares Issued, Price Per Share       $ 6.48        
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member] | Series A Preferred Stock [Member]                
Product Information [Line Items]                
Stock Issued During Period, Shares, New Issues       46,868        
American Pacific Bancorp [Member]                
Product Information [Line Items]                
Stock Issued During Period, Shares, New Issues     6,666,700          
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned     $ 40,000,000          
Business Acquisition, Share Price     $ 6.00          
Equity Method Investment, Ownership Percentage     2.00%          
American Pacific Bancorp [Member] | Common Class A [Member]                
Product Information [Line Items]                
Common Stock, Par or Stated Value Per Share     $ 0.01          
American Pacific Bancorp [Member] | Stock Purchase Agreement [Member]                
Product Information [Line Items]                
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned     $ 40,000,200          
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares     6,666,700          
Business Acquisition, Share Price     $ 6.00          
American Pacific Bancorp [Member] | Stock Purchase Agreement [Member] | Common Class A [Member]                
Product Information [Line Items]                
Common Stock, Par or Stated Value Per Share     $ 0.01          
Liquid Asset Limited Management Limited [Member] | Stock Purchase Agreement [Member]                
Product Information [Line Items]                
Business Acquisition, Description of Acquired Entity   Under the terms of this agreement, 4000 shares or 40% of the Company’s subsidiary Liquid Asset Limited Management Limited (“LVAM”), a Hong Kong company was transferred to HR1 whereas at the conclusion of the transaction DFMI would own 60% of LVAM and HR1 would own 40%            
Sharing Services Global Corp [Member]                
Product Information [Line Items]                
Equity Method Investment, Description of Principal Activities         On December 23, 2021, DSS purchased 50,000,000      
Stock Repurchased During Period, Shares 50,000,000              
Share Price $ 0.06              
Equity Method Investment, Ownership Percentage 58.00%